Table 2.
Baseline characteristics for the whole sample and by trial arm.
| Variable | All (N=41) | IGa (n=21) | CGb (n=20) | ||||
| Age, mean (SD) | 54.3 (11) | 52.6 (11) | 56.2 (12) | ||||
| Female, n (%) | 32 (78) | 17 (81) | 15 (75) | ||||
| White ethnicity, n (%) | 36 (88) | 19 (90) | 17 (85) | ||||
| Married or living with partner, n (%) | 30 (73) | 17 (81) | 13 (65) | ||||
| Employed, n (%) | 21 (51) | 11 (52) | 10 (50) | ||||
| Cut work hours due to cancer, n (%) | 20 (49) | 14 (67) | 6 (30) | ||||
| Possessed postschool qualifications, n (%) | 24 (58) | 12 (57) | 12 (60) | ||||
| Still undergoing treatment for cancer, n (%) | 17 (41) | 9 (43) | 8 (40) | ||||
| Cancer type, n (%) | |||||||
|
|
Breast | 17 (41) | 8 (38) | 9 (45) | |||
|
|
Gynecological | 4 (10) | 0 (0) | 4 (20) | |||
|
|
Prostate | 2 (5) | 0 (0) | 2 (10) | |||
|
|
Lung | 3 (7) | 2 (9) | 1 (5) | |||
|
|
Colorectal | 3 (7) | 3 (14) | 0 (0) | |||
|
|
Gastrointestinal | 2 (5) | 0 (0) | 2 (10) | |||
|
|
Bladder or kidney | 1 (2) | 0 (0) | 1 (5) | |||
|
|
Head or neck | 4 (19) | 2 (9) | 2 (5) | |||
|
|
Other | 9 (22) | 8 (38) | 1 (5) | |||
aIG: intervention group.
bCG: control group.